• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发热性尿路感染男性患者随访1年期间游离、复合及总血清前列腺特异性抗原及其比值的变化

Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection.

作者信息

Zackrisson Björn, Ulleryd Peter, Aus Gunnar, Lilja Hans, Sandberg Torsten, Hugosson Jonas

机构信息

Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden.

出版信息

Urology. 2003 Aug;62(2):278-81. doi: 10.1016/s0090-4295(03)00372-8.

DOI:10.1016/s0090-4295(03)00372-8
PMID:12893335
Abstract

OBJECTIVES

To determine the serum values of free, complexed, and total prostate-specific antigen (PSA) and their ratios in men with febrile urinary tract infection (UTI) during 1 year of follow-up.

METHODS

A total of 54 men were prospectively enrolled in the study, and serum samples were obtained at the acute stage of the UTI and after 1, 3, 6, and 12 months.

RESULTS

Most men had a rise (median 3.1, 7.2, and 14.1 ng/mL, respectively) in free PSA (fPSA), complexed PSA (cPSA), and total PSA (tPSA) during the acute phase of the UTI. After 1 month, fPSA rapidly decreased to levels that were maintained during the rest of the follow-up period, and cPSA and tPSA declined more slowly. At 1, 3, and 6 months after the infection the fPSA/tPSA and fPSA/cPSA ratios were abnormal in one half to two thirds of the men (median ratio 11%, 15%, and 16% and 17%, 24%, and 24%, respectively), comparable to findings in patients with prostate cancer.

CONCLUSIONS

These results confirmed that the prostate is involved in men with febrile UTI. The low fPSA/tPSA and fPSA/cPSA ratios in combination with sustained elevations of cPSA and tPSA for up to 6 months after UTI could be falsely interpreted as a sign of prostate cancer. The prolonged elevation of cPSA indicates a long-lasting inflammation of the nonadenomatous parts of the prostate.

摘要

目的

确定发热性尿路感染(UTI)男性患者在1年随访期间游离、复合及总前列腺特异性抗原(PSA)的血清值及其比率。

方法

共有54名男性前瞻性纳入本研究,在UTI急性期以及1、3、6和12个月后采集血清样本。

结果

大多数男性在UTI急性期游离PSA(fPSA)、复合PSA(cPSA)和总PSA(tPSA)升高(中位数分别为3.1、7.2和14.1 ng/mL)。1个月后,fPSA迅速降至随访期其余时间维持的水平,而cPSA和tPSA下降较慢。感染后1、3和6个月,一半至三分之二的男性fPSA/tPSA和fPSA/cPSA比率异常(中位数比率分别为11%、15%和16%以及17%、24%和24%),与前列腺癌患者的结果相当。

结论

这些结果证实前列腺参与了发热性UTI男性患者的发病过程。UTI后长达6个月fPSA/tPSA和fPSA/cPSA比率低,同时cPSA和tPSA持续升高,可能会被错误地解读为前列腺癌的迹象。cPSA的长期升高表明前列腺非腺瘤部分存在持久炎症。

相似文献

1
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection.发热性尿路感染男性患者随访1年期间游离、复合及总血清前列腺特异性抗原及其比值的变化
Urology. 2003 Aug;62(2):278-81. doi: 10.1016/s0090-4295(03)00372-8.
2
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.游离前列腺特异性抗原、α1抗糜蛋白酶结合型前列腺特异性抗原及复合前列腺特异性抗原在前列腺癌诊断中临床有效性的比较
Eur Urol. 2001 Jan;39(1):57-64. doi: 10.1159/000052413.
3
Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.游离、复合及总前列腺特异性抗原的各种组合用于检测前列腺癌的比较。
Eur Urol. 2000 Oct;38(4):380-7. doi: 10.1159/000020312.
4
Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.血清总前列腺特异性抗原在4.1至10 ng/mL之间的男性重复前列腺活检中前列腺癌的预测因素。
Int J Urol. 2003 Apr;10(4):201-6. doi: 10.1046/j.0919-8172.2003.00605.x.
5
Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?游离或复合前列腺特异性抗原(PSA)与总PSA的比值:哪种比值能改善良性前列腺增生与前列腺癌之间的鉴别诊断?
Clin Chem. 2000 Jan;46(1):55-62.
6
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.复合前列腺特异性抗原、总前列腺特异性抗原及移行区的复合前列腺特异性抗原密度、复合/总前列腺特异性抗原比值、游离/总前列腺特异性抗原比值、总前列腺特异性抗原及移行区前列腺特异性抗原密度:欧洲前瞻性多中心试验结果
Urology. 2002 Oct;60(4 Suppl 1):4-9. doi: 10.1016/s0090-4295(02)01896-4.
7
Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.两种检测方法对总前列腺特异性抗原中复合前列腺特异性抗原在4.1至10.0 ng/mL之间的比较。
Urology. 2000 May;55(5):700-4. doi: 10.1016/s0090-4295(99)00589-0.
8
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.复合前列腺特异性抗原提高了前列腺癌检测的特异性:一项前瞻性多中心临床试验的结果。
J Urol. 2003 Nov;170(5):1787-91. doi: 10.1097/01.ju.0000092695.55705.dd.
9
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.总前列腺特异性抗原、游离前列腺特异性抗原和复合前列腺特异性抗原的体积指数可增强对不可触及前列腺癌男性患者前列腺外疾病扩展的预测。
Urology. 2003 Dec;62(6):1058-62. doi: 10.1016/j.urology.2003.07.016.
10
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?血清中总前列腺特异性抗原浓度<4μg/L时前列腺特异性抗原的分子形式:它们是早期检测和筛查前列腺癌的有用工具吗?
Int J Cancer. 2001 Sep 1;93(5):759-65. doi: 10.1002/ijc.1393.

引用本文的文献

1
Clinical Outcomes of Acute Bacterial Prostatitis: A Comparative Study of Oral Sequential Therapy with β-Lactam Versus Quinolone Antibiotics.急性细菌性前列腺炎的临床结果:β-内酰胺类抗生素与喹诺酮类抗生素口服序贯疗法的比较研究
Antibiotics (Basel). 2025 Jul 5;14(7):681. doi: 10.3390/antibiotics14070681.
2
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up.感染对前列腺特异性抗原浓度的持续影响:一项为期10年随访的变化分析。
Prostate. 2018 Sep;78(13):1024-1034. doi: 10.1002/pros.23660. Epub 2018 May 30.
3
Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.
组织学炎症对无临床可检测前列腺癌患者血清总前列腺特异性抗原和游离前列腺特异性抗原值的影响。
Korean J Urol. 2014 Aug;55(8):527-32. doi: 10.4111/kju.2014.55.8.527. Epub 2014 Aug 8.
4
Screening for prostate cancer: early detection or overdetection?前列腺癌筛查:早期发现还是过度诊断?
Annu Rev Med. 2012;63:161-70. doi: 10.1146/annurev-med-050710-134421. Epub 2011 Nov 3.
5
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.前列腺激肽释放酶标志物在诊断、风险分层和预后中的作用。
Nat Rev Urol. 2009 Jul;6(7):384-91. doi: 10.1038/nrurol.2009.123.